The importance of GRAS to the functional food and nutraceutical industries

Toxicology

Volumn 221, Issue 1, 2006, Pages 17-27

  Burdock, George A ^a   Carabin, Ioana G ^b   Griffiths, James C ^a  

^a Burdock Group   (United States)

^b Women in Science   (United States)

Author keywords

Dietary Supplement Health and Education Act (DSHEA); FDA; Functional foods; Generally recognized as safe (GRAS); New dietary ingredient notifications (NDIN); Nutraceuticals

Indexed keywords

CELECOXIB; CHOLESTIN; MEVINOLIN; NUTRACEUTICAL; PYRIDORIN; PYRIDOXAMINE; ROFECOXIB;

ARTICLE; CONSUMER ADVOCACY; CONSUMER HEALTH INFORMATION; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; FOOD INDUSTRY; FOOD QUALITY; FOOD SAFETY; FUNCTIONAL FOOD; HEALTH CARE POLICY; HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; REGULATORY MECHANISM;

CONSUMER PRODUCT SAFETY; DIETARY SUPPLEMENTS; FOOD INDUSTRY; FOOD LABELING; HEALTH FOOD; HUMANS; LEGISLATION, FOOD; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33644643867     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.01.012     Document Type: Article

References (13)

1. Anonymous, 1999. Executive summary, In: Proceedings of a Symposium on What is a Nutrient? Defining the Food-Drug Continuum, Georgetown University, Center for Food and Nutrition Policy, Ceres Forum, 30 March, p. 82.
2. R. Bailey Functional foods in Japan: FOSHU ("Foods for Specific health Uses") and "Foods with Nutrient Function Claims" C. Hasler Regulation of Functional Foods and Nutraceuticals 2005 Blackwell Publishing Ames, IA 247 261 (Chapter 15)
3. G.A. Burdock Dietary supplements and lessons to be learned from GRAS J. Regul. Toxicol. Pharmacol. 31 2000 68 76
4. G.A. Burdock, and I.C. Carabin Generally Recognized As Safe (GRAS): history and description Toxicol. Lett. 150 2004 3 18
5. Carabin, I.G., 2004a. The Clinical Aspects of Claim Substantiation: Clinical Trial Costs. FDLI Update, issue 4, pp. 39-43.
6. Carabin, I.G., 2004b. The Clinical Aspects of Claim Substantiation: Inclusion/Exclusion Criteria, Screening and Baseline Evaluations in Clinical Trials. FDLI Update, issue 5, pp. 41-45.
7. Council for Agricultural Science and Technology (CAST), 2003. Issue Paper No. 24, Nutraceuticals for Health Promotion and Disease Prevention. Camire, ME (chair). CAST, Ames, IA, 16 pp.
8. International Food Information Council (IFIC), 2005. Qualified Health Claims Consumer Research Project Executive Summary http://www.ific.org/research/ qualhealthclaimsres.cfm (site visited 25 December 2005).
9. J.C. Griffiths The value of playing it safe Funct. Foods Nutraceuticals 2005 24 28
10. D.A. Kracov, P.D. Rubin, and L.M. Dwyer Dietary supplements and drug constituents: the Pharmanex v. Shalala case and implications for the pharmaceutical and dietary supplement industries C. Hasler Regulation of Functional Foods, Nutraceuticals 2005 Blackwell Publishing Ames, IA 137 148 (Chapter 10)
11. S.B. Rowe Round table forum, moderators comments What is a Nutrient? Defining the Food-Drug Continuum 30 March, 1999 Georgetown University
12. A. Rulis Food safety and nutritional risk. bioactive food components CSL/JIFSAN Symposium on Food Safety and Nutrition July 2005
13. E.M. Walsh, E.K. Leitzan, and P.B. Hutt The importance of the court decision in Pearson v. Shalala to the marketing of conventional food and dietary supplements in the United States C. Hasler Regulation of Functional Foods and Nutraceuticals 2005 Blackwell Publishing Ames, IA 109 135 (Chapter 8)